4Liu C L, Lai E C S, Lo C M, et al. Combined laparoscopic and endoscopeic approach in patients with cholelithiasis and choledocholithiasis [J]. Surgery, 1996,119(5):534-537.
5Rolo AP, Palmeira CM, Wallace KB. Mitochondrially mediated synergistic cell killing by bile acids [J]. Biochim Biophys Acta, 2003,1637 (1):127 - 132.
6Crosignani A, Podda M, Battezzati PM, et al. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration [ J ]. Hepatology 1991,14(6) :1000- 1007.
7Palmeira CM, Rolo AP. Mitochondrially-mediated toxicity of bile acids [ J ]. Toxicology, 2004 , 203 ( 1 -3):1 -15.
8Rolo AP, Palmeira CM , Wallace KB. Mitochondrially mediated synergistic cell killing by bile acids [ J ]. Biochim Biophys Acta, 2003 1637(1) :127 - 132.
9Nakajima T, Okuda Y, Chisaki K, et al. Bile acids increase intra cellular Ca^2 + concentration and nitric oxide production in vascular endothelial cells [ J ]. Br J Pharmacol, 2000, 130(7) :1457 - 1467.
10Krahenbuhl S, Fischer S, Talos C, et al. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity : dose- response study in isolated rat liver mitochondria[J]. Hepatology, 1994 , 20 (6) :1595-1601.
1Jones C, Badger SA, Black JM, et al. The use of antiendotoxin peptides in obstructive jaundice endotoxemia[J]. Eur J Gastroenterol Hepatol, 2012, 24(3):248-254.
